The Cooper Companies Declares Cash Dividend
Jan 07, 2016 21:15 pm UTC| Business
PLEASANTON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that, consistent with the plan approved by its board of directors to pay annual dividends, the Company declared...
Heat Biologics to Present at Biotech Showcase 2016
Jan 07, 2016 21:14 pm UTC| Business
DURHAM, N.C., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc.(“Heat”) (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that...
Dermira Provides DRM01 and DRM04 Development Program Updates
Jan 07, 2016 21:05 pm UTC| Business
Enrollment Completed in DRM01 Phase 2b Acne Trial; Topline Data Expected in 2Q16 Topline Data for DRM04 Phase 3 Hyperhidrosis Program Expected Mid-2016 MENLO PARK, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Dermira,...
Jan 07, 2016 21:05 pm UTC| Business
FREMONT, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage pharmaceutical company, today announced the appointment of Konstantinos Alataris, Ph.D. as President and Chief...
Horizon Technology Finance Leads $15 Million Venture Loan for NOMi
Jan 07, 2016 21:05 pm UTC| Business
FARMINGTON, Conn. and NORCROSS, Ga., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured...
Ocera Appoints Dr. Stan Bukofzer as Chief Medical Officer
Jan 07, 2016 21:05 pm UTC| Business
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases,...
Revance Specifies 2016 Clinical Program Milestones
Jan 07, 2016 21:05 pm UTC| Business
NEWARK, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications,...